[1]
Ribnikar, D. et al. 2023. Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy: PIK3CA activating mutations in invasive lobular breast carcinoma. Radiology and Oncology. 57, 2 (Jun. 2023), 220–228.